160 related articles for article (PubMed ID: 32000458)
21. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
[TBL] [Abstract][Full Text] [Related]
22. Novel PMS1 alleles preferentially affect the repair of primer strand loops during DNA replication.
Erdeniz N; Dudley S; Gealy R; Jinks-Robertson S; Liskay RM
Mol Cell Biol; 2005 Nov; 25(21):9221-31. PubMed ID: 16227575
[TBL] [Abstract][Full Text] [Related]
23. Total laparoscopic limited anatomical resection for centrally located hepatocellular carcinoma in cirrhotic liver.
Ho CM; Wakabayashi G; Nitta H; Takahashi M; Takahara T; Ito N; Hasegawa Y
Surg Endosc; 2013 May; 27(5):1820-5. PubMed ID: 23233006
[TBL] [Abstract][Full Text] [Related]
24. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
[TBL] [Abstract][Full Text] [Related]
26. Usefulness and limitation of indocyanine green fluorescence for detection of peritoneal recurrence after hepatectomy for hepatocellular carcinoma: a case report.
Hayashi H; Shimizu A; Motoyama H; Kubota K; Notake T; Sugenoya S; Hosoda K; Yasukawa K; Kobayashi R; Soejima Y
BMC Surg; 2021 Mar; 21(1):107. PubMed ID: 33653302
[TBL] [Abstract][Full Text] [Related]
27. Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature.
Choi GH; Ann SY; Lee SI; Kim SB; Song IH
World J Gastroenterol; 2016 Nov; 22(41):9229-9234. PubMed ID: 27895410
[TBL] [Abstract][Full Text] [Related]
28. The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Yuan X; Cheng G; Yu J; Zheng S; Sun C; Sun Q; Li K; Lin Z; Liu T; Li P; Xu Y; Kong F; Bjorkholm M; Xu D
Oncotarget; 2017 Apr; 8(14):23120-23129. PubMed ID: 28416747
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
30. Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination-deficient hepatocellular carcinoma.
An J; Oh JH; Oh B; Oh YJ; Ju JS; Kim W; Kang HJ; Sung CO; Shim JH
Hepatology; 2023 Aug; 78(2):452-467. PubMed ID: 36177702
[TBL] [Abstract][Full Text] [Related]
31. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.
Miao R; Luo H; Zhou H; Li G; Bu D; Yang X; Zhao X; Zhang H; Liu S; Zhong Y; Zou Z; Zhao Y; Yu K; He L; Sang X; Zhong S; Huang J; Wu Y; Miksad RA; Robson SC; Jiang C; Zhao Y; Zhao H
J Hepatol; 2014 Oct; 61(4):840-9. PubMed ID: 24859455
[TBL] [Abstract][Full Text] [Related]
32. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.
Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK
Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of a CT-guided hookwire marking in laparoscopic partial hepatectomy for hepatocellular carcinoma invisible on ultrasonography.
Monden K; Sadamori H; Hioki M; Nakano K; Asami S; Ohno S; Sasaki K; Ueki T; Yabushita K; Uka M; Hyodo T; Sakaguchi K; Takakura N
Asian J Endosc Surg; 2017 Feb; 10(1):100-103. PubMed ID: 28045236
[TBL] [Abstract][Full Text] [Related]
35. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.
Prolla TA; Baker SM; Harris AC; Tsao JL; Yao X; Bronner CE; Zheng B; Gordon M; Reneker J; Arnheim N; Shibata D; Bradley A; Liskay RM
Nat Genet; 1998 Mar; 18(3):276-9. PubMed ID: 9500552
[TBL] [Abstract][Full Text] [Related]
36. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.
Wang Q; Lasset C; Desseigne F; Saurin JC; Maugard C; Navarro C; Ruano E; Descos L; Trillet-Lenoir V; Bosset JF; Puisieux A
Hum Genet; 1999; 105(1-2):79-85. PubMed ID: 10480359
[TBL] [Abstract][Full Text] [Related]
38. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
[TBL] [Abstract][Full Text] [Related]
39. Synchronous occurrence of a hepatic myelolipoma and two hepatocellular carcinomas.
Xu SY; Xie HY; Zhou L; Zheng SS; Wang WL
World J Gastroenterol; 2016 Nov; 22(43):9654-9660. PubMed ID: 27920487
[TBL] [Abstract][Full Text] [Related]
40. [Contrast-enhanced sonography using Levovist is decisive for staging and therapeutic schedule in hepatocellular carcinoma].
von Herbay A; Donner A; Jung G; Vogt C; Häussinger D
Med Klin (Munich); 2004 Feb; 99(2):89-92. PubMed ID: 14963659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
